SWIXX BioPharma
SwitzerlandEntry
2021
Hold
5yr
Exit
2026
Who owns SWIXX BioPharma?
SWIXX BioPharma was owned by Merieux Equity Partners through Mérieux Participations 3 (2019 vintage) from 2021 to 2026, exited via Secondary.
Buyer identity available on Pro.
Hand-verified · updated 2026-05-07
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2026
More from Mérieux Participations 3
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Track SWIXX BioPharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy SWIXX BioPharma?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on SWIXX BioPharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue